171 related articles for article (PubMed ID: 25146833)
1. Epithelial dysplasia of the stomach with gastric immunophenotype shows features of biological aggressiveness.
Valente P; Garrido M; Gullo I; Baldaia H; Marques M; Baldaque-Silva F; Lopes J; Carneiro F
Gastric Cancer; 2015 Oct; 18(4):720-8. PubMed ID: 25146833
[TBL] [Abstract][Full Text] [Related]
2. Divergent expression of MUC5AC, MUC6, MUC2, CD10, and CDX-2 in dysplasia and intramucosal adenocarcinomas with intestinal and foveolar morphology: is this evidence of distinct gastric and intestinal pathways to carcinogenesis in Barrett Esophagus?
Khor TS; Alfaro EE; Ooi EM; Li Y; Srivastava A; Fujita H; Park Y; Kumarasinghe MP; Lauwers GY
Am J Surg Pathol; 2012 Mar; 36(3):331-42. PubMed ID: 22261707
[TBL] [Abstract][Full Text] [Related]
3. Gastric crypt dysplasia: a distinct subtype of gastric dysplasia with characteristic endoscopic features and immunophenotypic and biological anomalies.
Kim A; Ahn SJ; Park DY; Lee BE; Song GA; Kim GH; Lauwers GY
Histopathology; 2016 May; 68(6):843-9. PubMed ID: 26336971
[TBL] [Abstract][Full Text] [Related]
4. Adenomatous and foveolar gastric dysplasia: distinct patterns of mucin expression and background intestinal metaplasia.
Park DY; Srivastava A; Kim GH; Mino-Kenudson M; Deshpande V; Zukerberg LR; Song GA; Lauwers GY
Am J Surg Pathol; 2008 Apr; 32(4):524-33. PubMed ID: 18300795
[TBL] [Abstract][Full Text] [Related]
5. CDX2 expression in the intestinal-type gastric epithelial neoplasia: frequency and significance.
Park DY; Srivastava A; Kim GH; Mino-Kenudson M; Deshpande V; Zukerberg LR; Song GA; Lauwers GY
Mod Pathol; 2010 Jan; 23(1):54-61. PubMed ID: 19820687
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of gastric and biliary phenotype in pyloric-gland type adenoma of the gallbladder: immunohistochemical analysis of mucin profile and CD10.
Nagata S; Ajioka Y; Nishikura K; Watanabe G; Inoue T; Yamaguchi K; Watanabe H; Tanaka M; Tsuneyoshi M
Oncol Rep; 2007 Apr; 17(4):721-9. PubMed ID: 17342306
[TBL] [Abstract][Full Text] [Related]
7. Intestinal metaplasia of the stomach and esophagus: an immunohistochemical study of 60 cases including comparison with normal and inflamed intestinal mucosa.
Chlumská A; Mukenšnabl P; Mareček P; Zámečník M
Cesk Patol; 2014 Jul; 50(3):141-8. PubMed ID: 25186595
[TBL] [Abstract][Full Text] [Related]
8. Adenomas of the gallbladder. Morphologic features, expression of gastric and intestinal mucins, and incidence of high-grade dysplasia/carcinoma in situ and invasive carcinoma.
Albores-Saavedra J; Chablé-Montero F; González-Romo MA; Ramírez Jaramillo M; Henson DE
Hum Pathol; 2012 Sep; 43(9):1506-13. PubMed ID: 22386521
[TBL] [Abstract][Full Text] [Related]
9. Pyloric gland adenoma: an entity distinct from gastric foveolar type adenoma.
Chen ZM; Scudiere JR; Abraham SC; Montgomery E
Am J Surg Pathol; 2009 Feb; 33(2):186-93. PubMed ID: 18830123
[TBL] [Abstract][Full Text] [Related]
10. Esophageal dysplasia and adenocarcinoma: a study with double immunostaining for intestinal and gastric markers.
Chlumská A; Mukenšnabl P; Waloschek T; Zámečník M
Cesk Patol; 2018; 54(2):81-85. PubMed ID: 30441967
[TBL] [Abstract][Full Text] [Related]
11. Gastric dysplasias. A clinicopathological study of 35 cases.
Chlumská A; Mukenšnabl P; Waloschek T; Zámečník M
Cesk Patol; 2013 Jan; 49(1):35-8. PubMed ID: 23432074
[TBL] [Abstract][Full Text] [Related]
12. Pyloric gland adenoma: a histologic, immunohistochemical and molecular genetic study of 23 cases.
Chlumská A; Waloschek T; Mukenšnabl P; Martínek P; Kašpírková J; Zámečník M
Cesk Patol; 2015; 51(3):137-43. PubMed ID: 26421956
[TBL] [Abstract][Full Text] [Related]
13. CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer.
Liu Q; Teh M; Ito K; Shah N; Ito Y; Yeoh KG
Mod Pathol; 2007 Dec; 20(12):1286-97. PubMed ID: 17906616
[TBL] [Abstract][Full Text] [Related]
14. Cdx2 expression and its promoter methylation during metaplasia-dysplasia-carcinoma sequence in Barrett's esophagus.
Makita K; Kitazawa R; Semba S; Fujiishi K; Nakagawa M; Haraguchi R; Kitazawa S
World J Gastroenterol; 2013 Jan; 19(4):536-41. PubMed ID: 23382633
[TBL] [Abstract][Full Text] [Related]
15. Phenotype analysis by MUC2, MUC5AC, MUC6, and CD10 expression in Epstein-Barr virus-associated gastric carcinoma.
Barua RR; Uozaki H; Chong JM; Ushiku T; Hino R; Chang MS; Nagai H; Fukayama M
J Gastroenterol; 2006 Aug; 41(8):733-9. PubMed ID: 16988760
[TBL] [Abstract][Full Text] [Related]
16. Risk factors in malignant transformation of gastric epithelial neoplasia categorized by the revised Vienna classification: endoscopic, pathological, and immunophenotypic features.
Jung SH; Chung WC; Lee KM; Paik CN; Jung JH; Lee MK; Lee YK; Chung IS
Gastric Cancer; 2010 Jun; 13(2):123-30. PubMed ID: 20602200
[TBL] [Abstract][Full Text] [Related]
17. CDX-2 homeobox gene expression in human gastric carcinoma and precursor lesions.
Kim HS; Lee JS; Freund JN; Min KW; Lee JS; Kim W; Juhng SW; Park CS
J Gastroenterol Hepatol; 2006 Feb; 21(2):438-42. PubMed ID: 16509871
[TBL] [Abstract][Full Text] [Related]
18. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression.
Reis CA; David L; Correa P; Carneiro F; de Bolós C; Garcia E; Mandel U; Clausen H; Sobrinho-Simões M
Cancer Res; 1999 Mar; 59(5):1003-7. PubMed ID: 10070955
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma.
Jun SY; Eom DW; Park H; Bae YK; Jang KT; Yu E; Hong SM
Mod Pathol; 2014 Oct; 27(10):1364-74. PubMed ID: 24603585
[TBL] [Abstract][Full Text] [Related]
20. Differentiation reprogramming in gastric intestinal metaplasia and dysplasia: role of SOX2 and CDX2.
Camilo V; Garrido M; Valente P; Ricardo S; Amaral AL; Barros R; Chaves P; Carneiro F; David L; Almeida R
Histopathology; 2015 Feb; 66(3):343-50. PubMed ID: 25196071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
